{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": null, "lead_paragraph": "Africans seeking a drug to help contain the Ebola virus will have to wait months before a potentially life-saving experimental treatment used on two infected Americans is produced even in small amounts, officials said.", "headline": {"main": "Africans Face Long Wait for Unproven Ebola Drug", "print_headline": "Africans Face Long Wait for Unproven Ebola Drug"}, "abstract": null, "print_page": null, "word_count": "1071", "_id": "53e35c4e79881023cc86df37", "snippet": "Africans seeking a drug to help contain the Ebola virus will have to wait months before a potentially life-saving experimental treatment used on two infected Americans is produced even in small amounts, officials said.", "source": "AP", "slideshow_credits": null, "web_url": "http://www.nytimes.com/aponline/2014/08/07/world/africa/ap-af-west-africa-ebola.html", "multimedia": [], "subsection_name": "Africa", "keywords": [], "byline": {"person": [], "original": "By THE ASSOCIATED PRESS", "organization": "THE ASSOCIATED PRESS"}, "document_type": "article", "pub_date": "2014-08-07T06:58:19Z", "section_name": "World"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "Inmates, likelier than the general population to have Hepatitis C, also have a constitutional right to medical care.", "headline": {"main": "Why the Hepatitis Cure Sovaldi Is a Budgetary Disaster for Prisons", "kicker": "The Upshot", "print_headline": "Boon for Hepatitis C Patients, Disaster for Prison Budgets", "content_kicker": "Losing Cost Control"}, "abstract": "The Upshot; new hepatitis C drug Sovaldi sells for $1,000 a pill and costs $84,000 for a typical patient, major concern for prison systems, which have a disproportionate share of hepatitis C patients.", "print_page": "3", "word_count": "959", "_id": "53e3010c79881023cc86de73", "snippet": "Inmates, likelier than the general population to have Hepatitis C, also have a constitutional right to medical care.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/08/07/upshot/why-the-hepatitis-cure-sovaldi-is-a-budgetary-disaster-for-prisons.html", "multimedia": [{"subtype": "wide", "url": "images/2014/08/07/upshot/07up-prison/07up-prison-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2014/08/07/upshot/07up-prison/07up-prison-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2014/08/07/upshot/07up-prison/07up-prison-articleLarge.jpg", "height": 426, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2014/08/07/upshot/07up-prison/07up-prison-articleLarge.jpg", "xlargeheight": "426"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2014/08/07/upshot/07up-prison/07up-prison-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/08/07/upshot/07up-prison/07up-prison-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Sovaldi (Drug)", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Prisons and Prisoners", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Hepatitis", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Budgets and Budgeting", "is_major": "N", "rank": "4", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Margot", "lastname": "SANGER-KATZ"}], "original": "By MARGOT SANGER-KATZ"}, "document_type": "article", "pub_date": "2014-08-07T00:00:00Z", "section_name": "The Upshot"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "An experimental medicine that has been called a \u201csecret serum\u201d is being given to two Americans infected with Ebola.", "headline": {"main": "Ebola Therapy From an Obscure Biotech Firm Is Hurried Along", "print_headline": "An Obscure Biotech Firm Hurries Ebola Treatment"}, "abstract": "San Diego-based Mapp Biopharmaceuticals is focused on how to manufacture more of so-called secret serum ZMapp, which is being used for the first time to treat American patients infected with Ebola virus; World Health Organization has said it will convene panel of medical ethicists to explore use of experimental treatment in outbreak in West Africa.", "print_page": "1", "word_count": "1490", "_id": "53e2cfc979881023cc86de0e", "snippet": "An experimental medicine that has been called a \u201csecret serum\u201d is being given to two Americans infected with Ebola.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/08/07/business/an-obscure-biotech-firm-hurries-ebola-treatment.html", "multimedia": [{"subtype": "wide", "url": "images/2014/08/07/business/Drug1/Drug1-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2014/08/07/business/Drug1/Drug1-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2014/08/07/business/Drug1/Drug1-articleLarge.jpg", "height": 385, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2014/08/07/business/Drug1/Drug1-articleLarge.jpg", "xlargeheight": "385"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2014/08/07/business/Drug1/Drug1-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/08/07/business/Drug1/Drug1-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Ebola Virus", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "ZMapp (Drug)", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Mapp Biopharmaceutical Inc", "is_major": "Y", "rank": "3", "name": "organizations"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "4", "name": "subject"}, {"value": "Centers for Disease Control and Prevention", "is_major": "N", "rank": "5", "name": "organizations"}, {"value": "Food and Drug Administration", "is_major": "N", "rank": "6", "name": "organizations"}, {"value": "Brantly, Kent", "is_major": "N", "rank": "7", "name": "persons"}, {"value": "Writebol, Nancy", "is_major": "N", "rank": "8", "name": "persons"}, {"value": "Whaley, Kevin J", "is_major": "N", "rank": "9", "name": "persons"}, {"value": "Zeitlin, Laurence M", "is_major": "N", "rank": "10", "name": "persons"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2014-08-07T00:00:00Z", "section_name": "Business Day"}, {"type_of_material": "News", "blog": [], "news_desk": "Foreign", "lead_paragraph": "The World Health Organization also said it was convening a panel to evaluate the possibility of using experimental treatments to combat the outbreak.", "headline": {"main": "Expert Panel to Consult on Ebola", "print_headline": "Expert Panel to Consult on Ebola"}, "abstract": "World Health Organization is scrambling to catch up with deadly Ebola virus outbreak, announcing that it is considering declaring an international public health emergency and will convene expert panel to explore experimental treatments for the incurable disease.", "print_page": "4", "word_count": "620", "_id": "53e2859979881023cc86dd0d", "snippet": "The World Health Organization also said it was convening a panel to evaluate the possibility of using experimental treatments to combat the outbreak.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/08/07/world/africa/who-weighing-emergency-decree-on-ebola.html", "multimedia": [{"subtype": "wide", "url": "images/2014/08/07/world/EBOLA01/EBOLA01-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2014/08/07/world/EBOLA01/EBOLA01-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2014/08/07/world/EBOLA01/EBOLA01-articleLarge.jpg", "height": 398, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2014/08/07/world/EBOLA01/EBOLA01-articleLarge.jpg", "xlargeheight": "398"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2014/08/07/world/EBOLA01/EBOLA01-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/08/07/world/EBOLA01/EBOLA01-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": "Africa", "keywords": [{"value": "Guinea", "is_major": "N", "rank": "5", "name": "glocations"}, {"value": "Sierra Leone", "is_major": "N", "rank": "7", "name": "glocations"}, {"value": "Epidemics", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Liberia", "is_major": "N", "rank": "6", "name": "glocations"}, {"value": "Nigeria", "is_major": "N", "rank": "8", "name": "glocations"}, {"value": "Ebola Virus", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "World Health Organization", "is_major": "Y", "rank": "2", "name": "organizations"}, {"value": "Samaritan's Purse", "is_major": "N", "rank": "4", "name": "organizations"}], "byline": {"contributor": "Denise Grady contributed reporting.", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Rick", "lastname": "GLADSTONE"}], "original": "By RICK GLADSTONE"}, "document_type": "article", "pub_date": "2014-08-07T00:00:00Z", "section_name": "World"}, {"type_of_material": "Blog", "blog": [], "news_desk": "Science", "lead_paragraph": null, "headline": {"main": "Prostate Cancer Screening Still Not Recommended for All", "kicker": "Well", "print_headline": "Study Backs Limited Use of Prostate Cancer Screening"}, "abstract": "A major European study has shown that blood test screening for prostate cancer saves lives, but doubts remain about whether the benefit is large enough to offset the harms caused by unnecessary biopsies and treatments that can render men incontinent and impotent.", "print_page": null, "word_count": "926", "_id": "53e2adba79881023cc86ddac", "snippet": "A major European study has shown that blood test screening for prostate cancer saves lives, but doubts remain about whether the benefit is large enough to offset the harms caused by unnecessary biopsies and treatments that can render men incontinent...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://well.blogs.nytimes.com/2014/08/06/prostate-cancer-screening-still-not-recommended-for-all/", "multimedia": [{"subtype": "wide", "url": "images/2013/06/03/health/well_men/well_men-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2013/06/03/health/well_men/well_men-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2013/06/03/health/well_men/well_men-articleLarge.jpg", "height": 421, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2013/06/03/health/well_men/well_men-articleLarge.jpg", "xlargeheight": "421"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2013/06/03/health/well_men/well_men-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2013/06/03/health/well_men/well_men-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Prostate Cancer", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Prostate Gland", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Cancer", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Tests (Medical)", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Lancet, The (Journal)", "is_major": "Y", "rank": "5", "name": "organizations"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Tara", "lastname": "PARKER-POPE"}], "original": "By TARA PARKER-POPE"}, "document_type": "blogpost", "pub_date": "2014-08-06T18:30:30Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": null, "lead_paragraph": "The use of an experimental drug to treat two Americans diagnosed with Ebola is raising ethical questions about who gets first access to unproven new therapies for the deadly disease. But some health experts fear debate over extremely limited doses will distract from tried-and-true measures to curb the growing outbreak &#8212; things like more rapidly identifying and isolating the sick.", "headline": {"main": "Ethical Issue: Who Gets Experimental Ebola Drug?", "print_headline": "Ethical Issue: Who Gets Experimental Ebola Drug?"}, "abstract": null, "print_page": null, "word_count": "939", "_id": "53e2960679881023cc86dd5c", "snippet": "The use of an experimental drug to treat two Americans diagnosed with Ebola is raising ethical questions about who gets first access to unproven new therapies for the deadly disease. But some health experts fear debate over extremely limited doses...", "source": "AP", "slideshow_credits": null, "web_url": "http://www.nytimes.com/aponline/2014/08/06/health/ap-us-med-ebola-drug.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [], "original": "By THE ASSOCIATED PRESS", "organization": "THE ASSOCIATED PRESS"}, "document_type": "article", "pub_date": "2014-08-06T16:53:57Z", "section_name": "Health"}, {"type_of_material": "Blog", "blog": [], "news_desk": "Science", "lead_paragraph": null, "headline": {"main": "Women Pace Marathons Better Than Men Do", "kicker": "Well"}, "abstract": "A study of thousands of racers provides unexpected insights into how both genders might improve their race times by noting how the other one runs.", "print_page": null, "word_count": "831", "_id": "53e1a8ee798810409a1b6a00", "snippet": "A study of thousands of racers provides unexpected insights into how both genders might improve their race times by noting how the other one runs.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://well.blogs.nytimes.com/2014/08/06/women-pace-marathons-better-than-men-do/", "multimedia": [{"subtype": "wide", "url": "images/2014/08/05/health/physed_marathon/physed_marathon-thumbWide-v2.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2014/08/05/health/physed_marathon/physed_marathon-thumbWide-v2.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2014/08/05/health/physed_marathon/physed_marathon-articleLarge.jpg", "height": 401, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2014/08/05/health/physed_marathon/physed_marathon-articleLarge.jpg", "xlargeheight": "401"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2014/08/05/health/physed_marathon/physed_marathon-thumbStandard-v2.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/08/05/health/physed_marathon/physed_marathon-thumbStandard-v2.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Men and Boys", "name": "subject", "rank": "3"}, {"value": "Medicine and Health", "name": "subject", "rank": "2"}, {"value": "Women and Girls", "name": "subject", "rank": "5"}, {"value": "Running", "name": "subject", "rank": "4"}, {"value": "Marathon Running", "name": "subject", "rank": "1"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Gretchen", "lastname": "REYNOLDS"}], "original": "By GRETCHEN REYNOLDS"}, "document_type": "blogpost", "pub_date": "2014-08-06T00:01:21Z", "section_name": "Health"}, {"type_of_material": "Blog", "blog": [], "news_desk": "OpEd", "lead_paragraph": null, "headline": {"main": "The Marijuana-Schizophrenia Link", "kicker": "Taking Note"}, "abstract": "The risk to a relatively small group is not sufficient reason to bar marijuana use for everyone else.", "print_page": null, "word_count": "376", "_id": "53dffc6d7988101c965a59d2", "snippet": "The risk to a relatively small group is not sufficient reason to bar marijuana use for everyone else.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://takingnote.blogs.nytimes.com/2014/08/04/the-marijuana-schizophrenia-link/", "multimedia": [], "subsection_name": null, "keywords": [{"value": "National Institute on Drug Abuse", "name": "organizations", "rank": "1"}, {"value": "Marijuana", "name": "subject", "rank": "1"}, {"value": "Schizophrenia", "name": "subject", "rank": "2"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Philip"}], "original": "By PHILIP M. BOFFEY"}, "document_type": "blogpost", "pub_date": "2014-08-04T17:33:21Z", "section_name": "Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "Society", "lead_paragraph": "The couple are both at Harvard, where the bride is a postdoctoral fellow and the groom is a microfabrication engineer.", "headline": {"main": "Francesca Gazzaniga and Richard Novak", "print_headline": "Francesca Gazzaniga, Richard Novak"}, "abstract": null, "print_page": "11", "word_count": "257", "_id": "53ddb76579881018c3d09260", "snippet": "The couple are both at Harvard, where the bride is a postdoctoral fellow and the groom is a microfabrication engineer.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/08/03/fashion/weddings/francesca-gazzaniga-and-richard-novak.html", "multimedia": [{"subtype": "wide", "url": "images/2014/08/03/fashion/weddings/03GAZZANIGAjpg/03GAZZANIGAjpg-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2014/08/03/fashion/weddings/03GAZZANIGAjpg/03GAZZANIGAjpg-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2014/08/03/fashion/weddings/03GAZZANIGAjpg/03GAZZANIGAjpg-articleLarge.jpg", "height": 400, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2014/08/03/fashion/weddings/03GAZZANIGAjpg/03GAZZANIGAjpg-articleLarge.jpg", "xlargeheight": "400"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2014/08/03/fashion/weddings/03GAZZANIGAjpg/03GAZZANIGAjpg-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/08/03/fashion/weddings/03GAZZANIGAjpg/03GAZZANIGAjpg-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": "Weddings/Celebrations", "keywords": [{"value": "Weddings and Engagements", "is_major": "N", "rank": "1", "name": "subject"}], "byline": [], "document_type": "article", "pub_date": "2014-08-03T00:00:00Z", "section_name": "Fashion & Style"}, {"type_of_material": "News", "blog": [], "news_desk": "SundayBusiness", "lead_paragraph": "To grab some of TV\u2019s ad dollars, the social network is trying to help advertisers reach the perfect customer.", "headline": {"main": "How Facebook Sold You Krill Oil", "print_headline": "How Facebook Sold You Krill Oil"}, "abstract": "Facebook, looking to grab some of television\u2019s ad dollars, is trying to help advertisers reach the perfect customer; social network holds 'publishing garages' to help clients like Reckitt Benckiser plan advertising initiatives; ads for company's MegaRed krill oil product reached 18.1 million women aged 45 and up on Facebook.", "print_page": "1", "word_count": "3532", "_id": "53dd586279881018c3d091de", "snippet": "To grab some of TV\u2019s ad dollars, the social network is trying to help advertisers reach the perfect customer.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/08/03/technology/how-facebook-sold-you-krill-oil.html", "multimedia": [{"subtype": "wide", "url": "images/2014/08/03/business/3-THUMBSTOPPER1/3-THUMBSTOPPER1-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2014/08/03/business/3-THUMBSTOPPER1/3-THUMBSTOPPER1-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2014/08/03/business/3-THUMBSTOPPER1/3-THUMBSTOPPER1-articleLarge.jpg", "height": 379, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2014/08/03/business/3-THUMBSTOPPER1/3-THUMBSTOPPER1-articleLarge.jpg", "xlargeheight": "379"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2014/08/03/business/3-THUMBSTOPPER1/3-THUMBSTOPPER1-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/08/03/business/3-THUMBSTOPPER1/3-THUMBSTOPPER1-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Facebook Inc", "is_major": "Y", "rank": "1", "name": "organizations"}, {"value": "Advertising and Marketing", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Data-Mining and Database Marketing", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Reckitt Benckiser", "is_major": "Y", "rank": "4", "name": "organizations"}, {"value": "Dietary Supplements and Herbal Remedies", "is_major": "Y", "rank": "5", "name": "subject"}, {"value": "Online Advertising", "is_major": "N", "rank": "6", "name": "subject"}, {"value": "Social Media", "is_major": "N", "rank": "7", "name": "subject"}, {"value": "Krill", "is_major": "N", "rank": "8", "name": "subject"}, {"value": "Fish and Other Marine Life", "is_major": "N", "rank": "9", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Vindu", "lastname": "GOEL"}], "original": "By VINDU GOEL"}, "document_type": "article", "pub_date": "2014-08-03T00:00:00Z", "section_name": "Technology"}], "meta": {"hits": 12, "offset": 0, "time": 49}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}